Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2013; 19(30): 4861-4866
Published online Aug 14, 2013. doi: 10.3748/wjg.v19.i30.4861
Figure 1
Figure 1 Relative risks and quantitative analysis. Panel A: Relative risks (RR) for the association between diabetes and pancreatic cancer according to the duration of the diabetes (originated from[63]). The risk disappears after 10 years; Panel B: Quantitative analysis of the timing of the genetic evolution of pancreatic cancer indicates that at least a decade is necessary between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell, that at least five more years are required for the acquisition of metastatic ability and patients usually die on an average of 2 years thereafter (originated from[87]).